StageBio Overview
- Year Founded
-
1999
- Status
-
Private
- Employees
-
125
- Latest Deal Type
-
Debt
- Financing Rounds
-
3
- Investments
-
4
StageBio General Information
Description
Provider of critical services in the pre-clinical research and development market catering to the bio-pharmaceutical and contract research organization industries. The company specializes in histology and pathology services for routine tissue analyses, efficacy determination for new compounds and devices, toxicologic evaluation of products subject to Food and Drug Administration approval, and detailed pathology reporting, enabling clients to get standard laboratory practice studies.
Contact Information
Website
www.stagebio.comCorporate Office
- 8415 Progress Drive
- Frederick, MD 21701
- United States
Corporate Office
- 8415 Progress Drive
- Frederick, MD 21701
- United States
StageBio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
StageBio Comparisons
Industry
Financing
Details
StageBio Competitors (9)
One of StageBio’s 9 competitors is Experimental Pathology Laboratories, a Corporation company based in Sterling, VA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Experimental Pathology Laboratories | Corporation | Sterling, VA | ||||
| Propath (UK) Ltd | Corporation | Hereford, United Kingdom | ||||
| NovoVita Histopath Laboratory | Corporation | Natick, MA | ||||
| Alturas Analytics | Corporation | Moscow, ID | ||||
| Melior Discovery | Venture Capital-Backed | Exton, PA |
StageBio Signals
StageBio Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
StageBio Investments (4)
StageBio’s most recent deal was a Buyout/LBO with TPL Path Labs. The deal was made on 21-Oct-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| TPL Path Labs | 21-Oct-2020 | Buyout/LBO | Laboratory Services (Healthcare) | ||
| Alizée Pathology | 07-Nov-2019 | Buyout/LBO | BPO/Outsource Services | ||
| Tox Path Specialists | 10-Apr-2019 | Buyout/LBO | Laboratory Services (Healthcare) | ||
| Vet Path Services | 11-Dec-2018 | Buyout/LBO | Laboratory Services (Healthcare) |
StageBio FAQs
-
When was StageBio founded?
StageBio was founded in 1999.
-
Where is StageBio headquartered?
StageBio is headquartered in Frederick, MD.
-
What is the size of StageBio?
StageBio has 125 total employees.
-
What industry is StageBio in?
StageBio’s primary industry is Laboratory Services (Healthcare).
-
Is StageBio a private or public company?
StageBio is a Private company.
-
What is StageBio’s current revenue?
The current revenue for StageBio is .
-
Who are StageBio’s investors?
Ampersand Capital Partners and Massachusetts Biomedical Initiatives have invested in StageBio.
-
Who are StageBio’s competitors?
Experimental Pathology Laboratories, Propath (UK) Ltd, NovoVita Histopath Laboratory, Alturas Analytics, and Melior Discovery are some of the 9 competitors of StageBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process